-+ 0.00%
-+ 0.00%
-+ 0.00%

Cosmos Health sees Cur18 generating over $2.5 million annual US revenue in 12-18 months

PUBT·04/30/2026 16:50:34
Listen to the news
Cosmos Health sees Cur18 generating over $2.5 million annual US revenue in 12-18 months
  • Cosmos Health projected Cur18 to generate more than $2.5 million in incremental annual revenue in United States within 12 to 18 months.
  • Forecast based on current commercialization strategy, internal assumptions on pricing, expected sales volumes, gradual distribution expansion.
  • Rollout planned in phases, starting with direct-to-consumer e-commerce channels.
  • Distribution strategy includes potential expansion into selected retail channels over time.
  • Cur18 is curcumin-based dietary supplement in company 18 Series nutraceutical portfolio, positioned in US turmeric/curcumin supplement category.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202604301250ACCESSWRNAPR_____1162888) on April 30, 2026, and is solely responsible for the information contained therein.